Sudhakar Katakam

Array ( [id] => 14516297 [patent_doc_number] => 10335382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-02 [patent_title] => Use of hydrogen sulfide synthesis inhibitors for cancer therapy [patent_app_type] => utility [patent_app_number] => 14/967649 [patent_app_country] => US [patent_app_date] => 2015-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13207 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14967649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10805155 [patent_doc_number] => 20160151312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'POLYAMINE TRANSPORT INHIBITORS AS NOVEL THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/962195 [patent_app_country] => US [patent_app_date] => 2015-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9374 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025107 [patent_doc_number] => 20160222062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Cyclic Amino Acid Molecules And Methods Of Preparing The Same' [patent_app_type] => utility [patent_app_number] => 14/962952 [patent_app_country] => US [patent_app_date] => 2015-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 16804 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11480540 [patent_doc_number] => 09587071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Conjugated gold nanoparticles' [patent_app_type] => utility [patent_app_number] => 14/962619 [patent_app_country] => US [patent_app_date] => 2015-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10118 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15054835 [patent_doc_number] => 10457706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Multivalent ligand-lipid constructs [patent_app_type] => utility [patent_app_number] => 15/528732 [patent_app_country] => US [patent_app_date] => 2015-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12247272 [patent_doc_number] => 09920037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Diaryl isoxazoline compound' [patent_app_type] => utility [patent_app_number] => 15/517731 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5475 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10790034 [patent_doc_number] => 20160136190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles' [patent_app_type] => utility [patent_app_number] => 14/934209 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15793 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14029425 [patent_doc_number] => 10226443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Methods for treating psoriatic arthritis [patent_app_type] => utility [patent_app_number] => 14/885084 [patent_app_country] => US [patent_app_date] => 2015-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 13992 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14885084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053256 [patent_doc_number] => 20160250217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'CRYSTALLINE FORM OF PEMIROLAST' [patent_app_type] => utility [patent_app_number] => 14/880922 [patent_app_country] => US [patent_app_date] => 2015-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17063 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14880922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10677826 [patent_doc_number] => 20160023971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'Process for Preparing C3-6 (Hydro)Fluoroalkenes by Dehydrohalogenating C3-6 Halo(Hydro)Fluoroalkanes in the Presence of a Zinc/Chromia Catalyst' [patent_app_type] => utility [patent_app_number] => 14/876445 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15845 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10677825 [patent_doc_number] => 20160023970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'Process for Preparing C3-6(Hydro)Fluoroalkenes by Dehydrohalogenating C3-6 Halo(Hydro)Fluoroalkanes in the Presence of a Zinc/Chromia Catalyst' [patent_app_type] => utility [patent_app_number] => 14/876384 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15788 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12506955 [patent_doc_number] => 09999760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => DVDMS sensitizer for cancer sonodynamic therapy [patent_app_type] => utility [patent_app_number] => 14/872470 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 3970 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10677842 [patent_doc_number] => 20160023988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'FLUORESCENT PROBE' [patent_app_type] => utility [patent_app_number] => 14/854779 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18589 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14854779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10475202 [patent_doc_number] => 20150360219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'REGENERATION OF CATALYST FOR HYDROGENATION OF SUGARS' [patent_app_type] => utility [patent_app_number] => 14/834677 [patent_app_country] => US [patent_app_date] => 2015-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8831 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11935063 [patent_doc_number] => 20170239212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'BRYOSTATIN ANALOGS AND USE THEREOF AS ANTIVIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 15/503495 [patent_app_country] => US [patent_app_date] => 2015-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 76394 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14116971 [patent_doc_number] => 10245326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Amantadine, memantine, and rimantadine conjugates and a pharmaceutical composition for treatment of neuronal disorders [patent_app_type] => utility [patent_app_number] => 14/819959 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10451866 [patent_doc_number] => 20150336880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'N-HYDROXYLSULFONAMIDE DERIVATIVES AS NEW PHYSIOLOGICALLY USEFUL NITROXYL DONORS' [patent_app_type] => utility [patent_app_number] => 14/815917 [patent_app_country] => US [patent_app_date] => 2015-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25318 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14815917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10761832 [patent_doc_number] => 20160107984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'MODULATOR' [patent_app_type] => utility [patent_app_number] => 14/809331 [patent_app_country] => US [patent_app_date] => 2015-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14809331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11669783 [patent_doc_number] => 20170158503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'PROCESS FOR USING BIOGENIC CARBON DIOXIDE DERIVED FROM NON-FOSSIL ORGANIC MATERIAL' [patent_app_type] => utility [patent_app_number] => 15/327345 [patent_app_country] => US [patent_app_date] => 2015-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31587 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13248861 [patent_doc_number] => 10137102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-27 [patent_title] => Oligomeric forms of 3-hydroxybutyrate [patent_app_type] => utility [patent_app_number] => 15/327395 [patent_app_country] => US [patent_app_date] => 2015-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6933 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327395 [rel_patent_id] =>[rel_patent_doc_number] =>)